Cargando…
Molecular Classification of Breast Cancer Tumours from Patients Treated with Doxorubicin and Docetaxel
It is known that four main molecular breast cancer subtypes have different prognoses and different responses to therapy. Luminal A tumours have a better prognosis and they tend to be sensitive to anti-estrogen drugs. Luminal B tumours have incomplete sensitivity to endocrine therapy. Her2 tumours, w...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Communications and Publications Division (CPD) of the IFCC
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975234/ https://www.ncbi.nlm.nih.gov/pubmed/27683343 |